Minerva Neurosciences | Ativo Circulante

Preço das Ações
6.33
Mudança Diária
0.02 0.32%
Mensal
46.53%
Anual
222.96%
Q1 Previsão
2.46




Ativo Circulante Alterar Data
Acadia Pharmaceuticals USD 1.08B 115.87M 2025-09
Adma Biologics USD 402.66M 3.1M 2025-09
ALKERMES USD 1.74B 106.38M 2025-09
Alterity Therapeutics Limited AUD 27.05M 6.16M 2023-06
AstraZeneca USD 28.72B 1.22B 2025-12
BioCryst Pharmaceuticals USD 355.68M 42.78M 2025-09
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Cipla INR 249.18B 16.3B 2025-09
Clal Biotechnology ILS 14.69M 1.95M 2023-12
Compugen USD 88.92M 8.72M 2025-09
CSL USD 11.85B 542M 2025-06
Dynavax Technologies USD 814.33M 28.62M 2025-09
Eli Lilly USD 62.07B 12.22B 2025-09
Esperion Therapeutics USD 360.46M 17.87M 2025-09
GlaxoSmithKline GBP 17.51B 332M 2025-12
Grifols EUR 6.28B 92.48M 2025-09
Halozyme Therapeutics USD 1.33B 206.08M 2025-09
Ionis Pharmaceuticals USD 2.52B 58.16M 2025-09
J&J USD 55.62B 1.01B 2025-12
Merck USD 47.56B 10.49B 2025-09
Minerva Neurosciences USD 13.02M 2.53M 2025-09
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Novartis USD 28.2B 2.26B 2025-09
Novavax USD 974.59M 55.08M 2025-09
Pfizer USD 46.92B 3.22B 2025-09
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.95B 3.09B 2025-12
Takeda JPY 3.12T 195.82B 2025-12
Vanda Pharmaceuticals USD 367.5M 27.42M 2025-09


Minerva Neurosciences Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.